Google

News for Acute Lymphocytic Leukemia 

Latest Acute Lymphocytic Leukemia News

Acute lymphoblastic leukemia (also called acute lymphocytic leukemia or ALL) is the most common form of leukemia in children, and the most common kind of childhood cancer.
This page is dedicated to latest news for patients, caregivers, physicians, and researchers whose interest is the acute lymphocytic leukemia. We hope you find this news site helpful and informative.

RSS Feed
Subscribe to Acute Lymphocytic Leukemia RSS Newsfeed.
email Report
 
Acute Lymphocytic Leukemia Resources    Link to us
 

Acute Lymphocytic Leukemia
Acute lymphocytic leukemia Definition Acute lymphocytic leukemia is a cancer of the white blood cells known as lymphocytes. Description Leukemia is a cancer of white blood cells. In acute leukemia, the cancerous cells are immature forms called blasts that cannot properly fight infection; patients

Genetic variants may ease leukemia risk.
People with acute lymphocytic leukemia are more likely than healthy people to have the common version of a gene that plays a role in regulating folic acid metabolism in the body, a new study shows. The gene encodes the enzyme methylene-tetrahydrofolate reductase (MTHFR), which acts on folic acid, a

Acute lymphocytic leukemia after fulminant varicella associated with severe neutropenia.
ABSTRACT Acute lymphocytic leukemia developed within 3 weeks after a fulminant case of varicella complicated by pneumococcal sepsis and severe bone marrow suppression in a child treated with filgrastim (human granulocyte colony-stimulating factor). VARICELLA is a common, usually benign, contagious

Acute lymphocytic leukemia in sporadic neurofibromatosis
Sir, Acute lymphocytic leukemia (ALL) is the most common pediatric malignancy accounting for 3/4face=+Superscript; thface=-Superscript; of all freshly diagnosed leukemias in childhood.face=+Superscript; [1]face=-Superscript; Neurofibromatosis (NF) is a common autosomal disorder with markedly

Randomized Trial of Two Therapies for Acute Lymphocytic Leukemia Finds Survival Advantage.
Byline: Memorial Sloan-Kettering Cancer Center ORLANDO, Fla., May 16 (AScribe Newswire) - A prospective, randomized trial comparing a novel regimen with a standard treatment for adult patients with acute lymphocytic leukemia (ALL) showed a distinct advantage that continued to show superior results

Allogeneic bone marrow transplant better than alternatives for ALL.
ORLANDO - Allogeneic stem cell transplants provide the most potent antileukemic therapy for standard-risk patients with acute lymphocytic leukemia in their first complete remission, according to a study reported at the annual meeting of the American Society of Hematology. The study also found that

Kids And Cancer.
For decades, American white children with acute lymphocytic leukemia (ALL), the most common childhood cancer, have for unknown reasons had a better chance of surviving than black kids. But a new study, published in the Journal of the American Medical Association, says the odds are virtually

UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL RESEARCHERS UNCOVER CLUES THAT MAY LEAD TO BETTER THERAPIES FOR CHILDREN WITH T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
The University of Massachusetts Medical School issued the following press release: Researchers' discovery of clues to the cause of T-cell acute lymphoblastic leukemia (T-ALL) - a form of pediatric cancer that has a very poor prognosis - could lead to the development of new targeted therapies for

acute lymphocytic leukemia
The Mosby Medical Encyclopedia 10-01-1996 acute lymphocytic leukemia (ALL) acute lymphoblastic leukemia, a blood cancer marked by many not-fully-formed white blood cells that collect in the bone marrow, the blood, the lymph nodes, the spleen, the liver, and other organs. The number of normal blood

Callisto Launches Milestone Clinical Trial of L-Annamycin to Treat Adult Relapsed or Refractory Acute Lymphocytic Leukemia ; First Clinical Trial Launched in Adult Patients with ALL at University of Texas M. D. Anderson Cancer Center.
NEW YORK - Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, announced today its milestone launching of the first clinical trial of an innovative new drug candidate, liposomal Annamycin (L-Annamycin),

 
Google
Breast Cancer News Colon Cancer News Lung Cancer News Prostate Cancer News Skin Cancer News Liver Cancer News Cancer News RSS Feeds The Basics explained Cancer News RSS Feeds